Skip to main content

Iheezo FDA Approval History

FDA Approved: Yes (First approved September 27, 2022)
Brand name: Iheezo
Generic name: chloroprocaine hydrochloride
Dosage form: Ophthalmic Gel
Company: Harrow
Treatment for: Ocular Surface Anesthesia

Last updated by Judith Stewart, BPharm on Sep 29, 2022.

Iheezo (chloroprocaine hydrochloride) is an ester anesthetic indicated for ocular surface anesthesia.

Development timeline for Iheezo

DateArticle
Sep 27, 2022Approval FDA Approves Iheezo (chloroprocaine hydrochloride ophthalmic gel) for Ocular Surface Anesthesia

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.